Penn Medicine Photodynamic Therapy Mesothelioma, Targeting Mesothelioma Pr News

Photodynamic therapy ptd is a promising new mesothelioma treatment still undergoing research in clinical trials.

Ms meyers cleaning. Researchers at penn medicine are investigating the addition of photodynamic therapy pdt to lung sparing radical pleurectomy and postoperative chemotherapy for the treatment of mesothelioma and pleural malignancies. Penn medicine abramson cancer center combines research innovative treatments and supportive care to help mesothelioma patients. It is based on the discovery that certain chemicals known as photosensitizing agents can kill organisms when they are exposed to a particular type of light.

1division of thoracic surgery university of pennsylvania school of medicine penn presbyterian medical center 51 n 39th street philadelphia pa 19104 usa. Photodynamic therapy pdt also known as photoradiation therapy phototherapy or photochemotherapy is used to treat certain types of cancer. In addition to the mesothelioma and pleural diseases program cengel also is director of the photodynamic therapy program a key component in the care of patients with pleural mesothelioma at the abramson cancer center.

Also known as photoradiation therapy phototherapy or photochemotherapy photodynamic therapy is based on a discovery that revealed that when light is exposed to certain chemicals at a particular frequency it can kill single cell organisms. A phase ii randomized study of photodynamic therapy in combination with pleurectomy surgery and post operative chemotherapy. The future of treatment.

Penn medicine was the first health system in the philadelphia area to begin researching the use of photodynamic therapy to treat mesothelioma patients. Mesothelioma treatment with photodynamic therapy penn was the first health system in the philadelphia area to begin researching the use of pdt to treat cancer. Philadelphia researchers at the perelman school of medicine at the university of pennsylvania in collaboration with the roswell park cancer institute have received an 8 million grant from the national cancer institute to study the effects of photodynamic light therapy pdt in patients with malignant pleural mesothelioma a rare aggressive and deadly cancer that most often manifests.

Photodynamic therapy for malignant pleural mesothelioma. Among patients with malignant pleural mesothelioma treatment with lung sparing surgery in combination with photodynamic therapy pdt yielded unusually long survival rates with median survival rates up to two or more years longer than is reported with traditional treatments according to new research from the perelman school of medicine at the univ.